Zimmer Biomet, a global medical technology company, agreed to acquire Embody, a privately-held medical device company, for $155m. "Embody's differentiated products and innovative pipeline in the area of sports medicine support our continued focus on and investment in high-growth markets and underscores our commitment to bringing meaningful new advances to patients and surgeons. The planned acquisition of Embody is an important step in the ongoing transformation of ZB and the execution of our strategic priority to increase long-term growth and drive value creation," Bryan Hanson, Zimmer Biomet Chairman, President and CEO.